CT-2074

N/A

Report date: 2022/02/21 10:52:59
NME

Base Information

Drug NameCT-2074
Drug Alias NameCT-2074
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSigma-2 receptor modulators
TargetsSigma-2 receptor
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCognition Therapeutics Llc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A